U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C32H67O4P
Molecular Weight 546.8457
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DIHEXADECYL PHOSPHATE

SMILES

CCCCCCCCCCCCCCCCOP(O)(=O)OCCCCCCCCCCCCCCCC

InChI

InChIKey=RNPXCFINMKSQPQ-UHFFFAOYSA-N
InChI=1S/C32H67O4P/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-35-37(33,34)36-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h3-32H2,1-2H3,(H,33,34)

HIDE SMILES / InChI

Molecular Formula C32H67O4P
Molecular Weight 546.8457
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Palliative
CYHOT Cream with Lidocaine Well at WAlgreens

Approved Use

Temporarily relieves pain and itching due to: • sunburn • minor burns • minor cuts • scrapes • insect bites

Launch Date

2017
PubMed

PubMed

TitleDatePubMed
Development of naftifine hydrochloride alcohol-free niosome gel.
2009-05
The enhancement of immunosuppressive effects of cyclosporine A on human T-cells using fusogenic liposomes.
2008-12-01
Spin labelling study of interfacial properties of egg-phosphatidylcholine liposomes as a function of cholesterol concentrations.
2008-10
Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes.
2008-09-01
Cationic nanoparticles for delivery of amphotericin B: preparation, characterization and activity in vitro.
2008-05-07
Spontaneous vesicles of sodium dihexadecylphosphate in HEPES buffer.
2008-04-15
Self-assembly of electroactive layer-by-layer films of heme proteins with anionic surfactant dihexadecyl phosphate.
2008-04
Effect of charged and non-ionic membrane additives on physicochemical properties and stability of niosomes.
2008
Optimization of formulation variables of benzocaine liposomes using experimental design.
2008
Niosome-encapsulated gentamicin for ophthalmic controlled delivery.
2008
Enhanced transdermal delivery of salbutamol sulfate via ethosomes.
2007-12-14
Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits.
2007-12-14
Interaction and transport of poly(L-lysine) dendrigrafts through liposomal and cellular membranes: the role of generation and surface functionalization.
2007-10
Comparative characterization of the physicochemical behavior and skin permeation of extruded DPPC liposomes modified by selected additives.
2007-08
Immuno-targeting of nonionic surfactant vesicles to inflammation.
2007-07-18
Fatty alcohols or fatty acids as niosomal hybrid carrier: effect on vesicle size, encapsulation efficiency and in vitro dye release.
2007-07-01
Preparation of liposomal gene therapy vectors by a scalable method without using volatile solvents or detergents.
2007-05-10
Study on the electrochemical behavior and differential pulse voltammetric determination of rhein using a nanoparticle composite film-modified electrode.
2007-05
Direct electrochemistry of glucose oxidase in a colloid Au-dihexadecylphosphate composite film and its application to develop a glucose biosensor.
2007-05
Preparation of an ion-exchangeable polymer bead wrapped with bilayer membrane structures for high performance liquid chromatography.
2007-04-18
Ultrasound enhancement of drug release across non ionic surfactant vesicle membranes.
2007-02-03
Liposomes and niosomes as potential carriers for dermal delivery of minoxidil.
2007-02
Skin permeation enhancement of ascorbyl palmitate by liposomal hydrogel (lipogel) formulation and electrical assistance.
2007-02
In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin.
2007-01-10
Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies.
2007-01-05
In vitro evaluation of enrofloxacin-loaded MLV liposomes.
2007-01
Microscopical investigations of nisin-loaded nanoliposomes prepared by Mozafari method and their bacterial targeting.
2007
Modeling cell membrane transport: interaction of guanidinylated poly(propylene imine) dendrimers with a liposomal membrane consisting of phosphate-based lipids.
2006-12-19
Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration.
2006-11
Ion distributions at charged aqueous surfaces by near-resonance X-ray spectroscopy.
2006-11
Enhancement of follicular delivery of finasteride by liposomes and niosomes 1. In vitro permeation and in vivo deposition studies using hamster flank and ear models.
2006-10-12
Tuberculosis chemotherapy: current drug delivery approaches.
2006-09-19
Influence of particle size on drug delivery to rat alveolar macrophages following pulmonary administration of ciprofloxacin incorporated into liposomes.
2006-09
Uptake of dexamethasone incorporated into liposomes by macrophages and foam cells and its inhibitory effect on cellular cholesterol ester accumulation.
2006-09
Electrochemical determination of 2-chlorophenol using an acetylene black film modified glassy carbon electrode.
2006-09
Action mechanism of water soluble ethanol on phospholipid monolayers using a quartz crystal oscillator.
2006-06-15
Electrochemical study of lincomycin on a multi-wall carbon nanotubes modified glassy carbon electrode and its determination in tablets.
2006-06-07
Electrochemistry and voltammetric determination of colchicine using an acetylene black-dihexadecyl hydrogen phosphate composite film modified glassy carbon electrode.
2006-05
A fibrin encapsulated liposomes-in-chitosan matrix (FLCM) for delivering water-soluble drugs. Influences of the surface properties of liposomes and the crosslinked fibrin network.
2006-03-27
Niosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin.
2006-03-27
Enhancement of the transdermal delivery of catechins by liposomes incorporating anionic surfactants and ethanol.
2006-03-09
ATP-dependent and drug-inhibited vesicle enlargement reconstituted using synthetic lipids and recombinant proteins.
2006
Colloid stability of sodium dihexadecyl phosphate/poly(diallyldimethylammonium chloride) decorated latex.
2005-10-11
Synthesis and biological evaluation of spin-labeled alkylphospholipid analogs.
2005-10-06
Effect of charge and lipid concentration on in-vivo percutaneous absorption of methyl nicotinate from liposomal vesicles.
2005-09
Interaction of functional dendrimers with multilamellar liposomes: design of a model system for studying drug delivery.
2005-08-02
Structure and temperature behavior of metallo-supramolecular assemblies.
2005-07-07
Application of protein-coupled liposomes to effective affinity screening from phage library.
2005-07-01
Efficient drug delivery to atherosclerotic lesions and the antiatherosclerotic effect by dexamethasone incorporated into liposomes in atherogenic mice.
2005-05
Determination of vesicle-water partition coefficients by electrokinetic chromatography: study of temperature effect.
2002-09-15
Patents
Substance Class Chemical
Created
by admin
on Wed Apr 02 17:56:59 GMT 2025
Edited
by admin
on Wed Apr 02 17:56:59 GMT 2025
Record UNII
2V6E5WN99N
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DIHEXADECYL PHOSPHATE
Systematic Name English
DICETYL PHOSPHATE
INCI  
INCI  
Preferred Name English
NSC-12429
Code English
DICETYLPHOSPHATE
Systematic Name English
Code System Code Type Description
CHEBI
60424
Created by admin on Wed Apr 02 17:56:59 GMT 2025 , Edited by admin on Wed Apr 02 17:56:59 GMT 2025
PRIMARY
PUBCHEM
75143
Created by admin on Wed Apr 02 17:56:59 GMT 2025 , Edited by admin on Wed Apr 02 17:56:59 GMT 2025
PRIMARY
ECHA (EC/EINECS)
218-594-7
Created by admin on Wed Apr 02 17:56:59 GMT 2025 , Edited by admin on Wed Apr 02 17:56:59 GMT 2025
PRIMARY
RXCUI
1314346
Created by admin on Wed Apr 02 17:56:59 GMT 2025 , Edited by admin on Wed Apr 02 17:56:59 GMT 2025
PRIMARY
DAILYMED
2V6E5WN99N
Created by admin on Wed Apr 02 17:56:59 GMT 2025 , Edited by admin on Wed Apr 02 17:56:59 GMT 2025
PRIMARY
MESH
C002290
Created by admin on Wed Apr 02 17:56:59 GMT 2025 , Edited by admin on Wed Apr 02 17:56:59 GMT 2025
PRIMARY
EVMPD
SUB181483
Created by admin on Wed Apr 02 17:56:59 GMT 2025 , Edited by admin on Wed Apr 02 17:56:59 GMT 2025
PRIMARY
FDA UNII
2V6E5WN99N
Created by admin on Wed Apr 02 17:56:59 GMT 2025 , Edited by admin on Wed Apr 02 17:56:59 GMT 2025
PRIMARY
NSC
12429
Created by admin on Wed Apr 02 17:56:59 GMT 2025 , Edited by admin on Wed Apr 02 17:56:59 GMT 2025
PRIMARY
EPA CompTox
DTXSID7062243
Created by admin on Wed Apr 02 17:56:59 GMT 2025 , Edited by admin on Wed Apr 02 17:56:59 GMT 2025
PRIMARY
CAS
2197-63-9
Created by admin on Wed Apr 02 17:56:59 GMT 2025 , Edited by admin on Wed Apr 02 17:56:59 GMT 2025
PRIMARY
SMS_ID
100000167132
Created by admin on Wed Apr 02 17:56:59 GMT 2025 , Edited by admin on Wed Apr 02 17:56:59 GMT 2025
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT